Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3010% below fair value

$20.82+0.15 (+0.73%)

Close on Nov 13, 2026Market cap $23.91BP/E –Yield 2.31%

Viatris operating margin

Operating margin is operating income as a percentage of revenue.

Viatris's operating margin for the twelve months ending Sep 30, 2026 was -0.0%. For fiscal 2025 it was -18.6%, against 0.1% the year before. The highest annual figure on record is 9.9% in fiscal 2022.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-18.6%	−18.7
FY2024	Dec 31, 2024	0.1%	−4.9
FY2023	Dec 31, 2023	5.0%	−5.0
FY2022	Dec 31, 2022	9.9%	+10.1
FY2021	Dec 31, 2021	-0.2%	+1.6
FY2020	Dec 31, 2020	-1.8%	−8.0
FY2019	Dec 31, 2019	6.2%	−1.7
FY2018	Dec 31, 2018	7.9%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	7.0%	+2.2
Q2 FY2026	Jun 30, 2026	0.2%	−6.3
Q1 FY2026	Mar 31, 2026	-2.3%	+86.3
Q4 FY2025	Dec 31, 2025	-5.2%	−0.1
Q3 FY2025	Sep 30, 2025	4.8%	−1.3
Q2 FY2025	Jun 30, 2025	6.5%	+12.8
Q1 FY2025	Mar 31, 2025	-88.6%	−94.1
Q4 FY2024	Dec 31, 2024	-5.1%	+6.7
Q3 FY2024	Sep 30, 2024	6.0%	−5.4
Q2 FY2024	Jun 30, 2024	-6.3%	−15.7
Q1 FY2024	Mar 31, 2024	5.6%	−5.2
Q4 FY2023	Dec 31, 2023	-11.8%	−6.7
Q3 FY2023	Sep 30, 2023	11.5%	−2.3
Q2 FY2023	Jun 30, 2023	9.4%	−3.9
Q1 FY2023	Mar 31, 2023	10.7%	−6.2
Q4 FY2022	Dec 31, 2022	-5.2%	−3.4
Q3 FY2022	Sep 30, 2022	13.7%	+5.9
Q2 FY2022	Jun 30, 2022	13.3%	+14.4
Q1 FY2022	Mar 31, 2022	16.9%	+22.9
Q4 FY2021	Dec 31, 2021	-1.8%	+22.5
Q3 FY2021	Sep 30, 2021	7.9%	−3.9
Q2 FY2021	Jun 30, 2021	-1.0%	−6.0
Q1 FY2021	Mar 31, 2021	-6.0%	−13.1
Q4 FY2020	Dec 31, 2020	-24.3%	–
Q3 FY2020	Sep 30, 2020	11.8%	–
Q2 FY2020	Jun 30, 2020	4.9%	–
Q1 FY2020	Mar 31, 2020	7.1%	–